Metastatic breast cancer is now considered a chronic condition with effective treatments that in many ways allow women to lead a normal or near normal life. Yet, many women live with the fear that their cancer may no longer be responding to medication or the disease has flared in advance of overt clinical symptoms. They believe that a simple bloodtest can effectively monitor medication and help detect recurrences of HER2 tumors. Plus, monitoring helps to reduce anxiety. Therein lies the value of monitoring serum HER2 for women with metastatic HER2 tumors--the possibility of real-time, actionable information and additional peace of mind.

Biotechnology

Martell Diagnostic Laboratories

William Johnson

Jeffrey Benson

Jolene Beisang

Steve Stoesz

The Leadership Team at Martell Diagnostic Laboratories is responsible for setting the strategic direction, ensuring financial stability, and overseeing operations to advance the company's mission of providing real-time, actionable monitoring for metastatic HER2 tumors. This team drives initiatives that enhance patient care, optimize business processes, and foster organizational growth.

Leadership Team

About

Team members

Other teams at Martell Diagnostic Laboratories

Advisory and Directorship Team